Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)

Conditions:   Glioblastoma;   Glioblastoma, WHO Grade IV
Interventions:   Drug: Temozolomide (TMZ);   Device: Optune System;   Drug: Pembrolizumab
Sponsors:   University of Florida;   NovoCure Ltd.
Not yet recruiting

http://ift.tt/2rxF8Y3